- 全部删除
您的购物车当前为空
Minretumomab(CC-49)是一种针对TAG-72(tumor-associated glycoprotein 72)的鼠源单克隆抗体,由B72.3抗体优化得到,可用于研究乳腺癌、结肠癌、肺癌和胰腺癌。

为众多的药物研发团队赋能,
让新药发现更简单!
Minretumomab(CC-49)是一种针对TAG-72(tumor-associated glycoprotein 72)的鼠源单克隆抗体,由B72.3抗体优化得到,可用于研究乳腺癌、结肠癌、肺癌和胰腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In stock | |
| 5 mg | ¥ 5,860 | In stock | |
| 10 mg | ¥ 7,890 | In stock | |
| 25 mg | ¥ 11,700 | In stock | |
| 50 mg | ¥ 15,800 | In stock |
Minretumomab 相关产品
| 产品描述 | Minretumomab (CC-49) is a mouse monoclonal antibody targeting TAG-72 (tumour-associated glycoprotein 72), optimised from the B72.3 antibody, and can be used for research into breast cancer, colon cancer, lung cancer, and pancreatic cancer. |
| 体内活性 | 方法: |
| 别名 | 明瑞莫单抗 |
| CAS No. | 195189-17-4 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容